title: [L-arginine and male infertility].
abstract: The clinical efficacy and acceptance of L-arginina HCL was tested in 40 infertile men. All of these men had a normal number of spermatozoa (> 20 million/ml), but a decreased motility; this decreased motility was not due to infection or to immunological disorders. The treatment consisted of 80 ml of 10% L-arginine HCL administered daily per os for 6 months. L-arginine HCL showed to be able to improve the motility of spermatozoa without any side-effects.
authors.affiliation: Scuola di Specializzazione in Andrologia, Università degli Studi di Pisa.
authors.forename: M
authors.initials: M
authors.lastname: Scibona
authors.forename: P
authors.initials: P
authors.lastname: Meschini
authors.forename: S
authors.initials: S
authors.lastname: Capparelli
authors.forename: C
authors.initials: C
authors.lastname: Pecori
authors.forename: P
authors.initials: P
authors.lastname: Rossi
authors.forename: G F
authors.initials: GF
authors.lastname: Menchini Fabris
mesh_terms: D001120:Arginine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007248:Infertility, Male / Q000188:drug therapy*; D008297:Male; D013081:Sperm Motility / Q000187:drug effects*
chemical_list: D001120:Arginine